REDAPT
Device
Smith+Nephew, Inc.
Total Payments
$2.4M
Transactions
1,458
Doctors
548
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $433,059 | 327 | 148 |
| 2023 | $450,902 | 166 | 86 |
| 2022 | $432,363 | 268 | 151 |
| 2021 | $647,234 | 400 | 194 |
| 2020 | $397,934 | 297 | 123 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Royalty or License | $1.4M | 130 | 59.7% |
| Unspecified | $445,563 | 67 | 18.9% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $240,979 | 53 | 10.2% |
| Travel and Lodging | $95,655 | 281 | 4.1% |
| Consulting Fee | $70,511 | 40 | 3.0% |
| Food and Beverage | $52,624 | 878 | 2.2% |
| Space rental or facility fees (teaching hospital only) | $31,701 | 7 | 1.3% |
| Debt forgiveness | $14,016 | 2 | 0.6% |
Payments by Type
General
$1.9M
1,391 transactions
Research
$445,563
67 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| A Multicenter, Post Market Clinical Follow-up Study of Subjects with the REDAPT Revision Monolithic Sleeveless Stem and/or Acetabular components Previously Implanted | Smith+Nephew, Inc. | $94,355 | 0 |
| 2-years outcomes of implanted REDAPT Fully Porous Cup and XLPE Liner | Smith+Nephew, Inc. | $69,928 | 0 |
| A Retrospective-Prospective Study of REDAPT Revision Femoral System Modular Stem and/or Acetabular components Previously Implanted | Smith+Nephew, Inc. | $46,665 | 0 |
| Data Capture relating to the REDAPT Porous Cups with XLPE Liners | Smith+Nephew, Inc. | $38,520 | 0 |
| Data Capture relating to the Retro/Prospective Multi-Centre Data Capture on REDAPT Sleeved Stem | Smith+Nephew, Inc. | $37,975 | 0 |
| Data Capture relating to the REDAPT Porous Cups with CLPE Liners | Smith+Nephew, Inc. | $37,331 | 0 |
| Data Capture relating to the REDAPT Revision Hip System and AFIT Anthology Hip Stem | Smith+Nephew, Inc. | $25,000 | 0 |
| Data Capture relating to the REDAPT Sleeved Stems | Smith+Nephew, Inc. | $22,750 | 0 |
| Data captured relating to the REDAPT revision Products | Smith+Nephew, Inc. | $15,525 | 0 |
| Data Capture relating to the REDAPT Sleeved Monolithic Stem | Smith+Nephew, Inc. | $7,105 | 0 |
Top Doctors Receiving Payments for REDAPT — Page 22
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , MD | Orthopaedic Surgery | Richmond, VA | $13.80 | 1 |
| , PA-C | Surgical | Danbury, CT | $13.80 | 1 |
| , MD | Orthopaedic Surgery | Brookfield, CT | $13.80 | 1 |
| Nicholas Hernandez | Orthopaedic Surgery | Rochester, MN | $13.58 | 1 |
| , MD | Orthopaedic Surgery | Oviedo, FL | $13.41 | 1 |
| , M.D | Orthopaedic Surgery | Hendersonville, TN | $13.18 | 1 |
| , M.D | Orthopaedic Surgery | Brighton, MA | $12.92 | 1 |
| , M.D | Specialist | Louisville, KY | $12.82 | 1 |
| , M.D | Orthopaedic Surgery | Chicago, IL | $12.74 | 1 |
| , M.D | Orthopaedic Surgery | Lebanon, NH | $12.71 | 1 |
| , MD | Orthopaedic Surgery | Hartford, CT | $12.70 | 1 |
| , MD | Orthopaedic Surgery | Salt Lake City, UT | $12.46 | 1 |
| , MD | Orthopaedic Surgery | Salisbury, NC | $12.22 | 1 |
| , M.D | Orthopaedic Surgery | Nellis Afb, NV | $11.98 | 1 |
| , M.D | Orthopaedic Trauma | Lima, OH | $11.69 | 1 |
| , MD | Orthopaedic Surgery | Philadelphia, PA | $11.07 | 1 |
| Sameer Naranje | Orthopaedic Surgery | Birmingham, AL | $11.07 | 1 |
| , M.D | Orthopaedic Surgery | Winter Garden, FL | $10.49 | 2 |
| , D.O | Orthopaedic Surgery | Newnan, GA | $10.16 | 1 |
| , M.D | Orthopaedic Surgery | Reno, NV | $8.58 | 1 |
| , M.D | Orthopaedic Surgery | Asheville, NC | $6.71 | 1 |
| , MD | Orthopaedic Surgery | Portland, OR | $4.25 | 1 |
| , MD | Sports Medicine | West Palm Beach, FL | $2.31 | 1 |
| , MD | Orthopaedic Surgery | West Palm Beach, FL | $2.31 | 1 |
Ad
Manufacturing Companies
- Smith+Nephew, Inc. $2.4M
Product Information
- Type Device
- Total Payments $2.4M
- Total Doctors 548
- Transactions 1,458
About REDAPT
REDAPT is a device associated with $2.4M in payments to 548 healthcare providers, recorded across 1,458 transactions in the CMS Open Payments database. The primary manufacturer is Smith+Nephew, Inc..
Payment data is available from 2020 to 2024. In 2024, $433,059 was paid across 327 transactions to 148 doctors.
The most common payment nature for REDAPT is "Royalty or License" ($1.4M, 59.7% of total).
REDAPT is associated with 10 research studies, including "A Multicenter, Post Market Clinical Follow-up Study of Subjects with the REDAPT Revision Monolithic Sleeveless Stem and/or Acetabular components Previously Implanted" ($94,355).